The original clip asks about receiving different types of COVID-19 vaccines and compares studies and vaccine platforms from the early period of the pandemic. This article explains the term “heterologous schedule” in the historical context of evidence from 2021; it is not a current vaccination schedule.
What does mixing vaccine types mean?
WHO uses this term when one vaccine product is given for the first dose and another for a later dose, or when different platforms are used for a booster. WHO’s December 16, 2021 document considered vaccine schedules involving products on the Emergency Use Listing as of December 7, 2021. It noted that direct evidence for some combinations was limited, making the guidance interim and specific to that period.
Why older studies are not today’s guidance
By 2026, product lists, updated vaccine formulations, recommended groups, and national policies have changed. WHO says mRNA and protein-based vaccines are now the main types in production, and current vaccination guidance focuses on people at higher risk. Saying one combination is “better” based on short-term immune responses in an older trial does not establish clinical outcomes or replace a current vaccination schedule.
How to use this article safely
Use the 2021 WHO page to understand the terminology and limits of evidence at that time. Before vaccination, check the latest guidance from Thai public-health authorities and speak with a healthcare provider, especially if you have a history of severe allergic reactions, an underlying condition, or use immunosuppressive medication.
Original video
Watch the original source linked in the article: Open on YouTube